Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan
TAIPEI, Taiwan, Dec. 8, 2021 /PRNewswire/ -- Bobby Sheng, chairman of Bora Pharmaceuticals (6472.TWO), today announced a partnership with Taishin Healthcare Limited Partnership at the 2021 Biotech Investor Forum, whereby the two parties will jointly invest up toNT$3 billion (approx. US$108 millio...
Bora Pharmaceuticals completes acquisition of former GSK facility
MISSISSAUGA, ON, Dec. 1, 2020 /PRNewswire/ -- Bora Pharmaceuticals Co., Ltd announced today that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK'sMississauga, Ontario (Canada) facility. Initially announced in March 2020, the s...